The ZILVERPASS study : comparing endovascular Zilver PTX DES treatment versus bypass surgery for femoral TASC C&D lesions

This presentation was presented by Dr. Marc Bosiers at the LINC 2017 Congress.

Preliminary 12-month results on 180 out of 220 patients & preliminary 24-month results on 110 out of 220 patients suggest at least a non-inferiority of Zilver PTX stenting versus prosthetic Above-The-Knee bypass surgery, with similar patency results and less complications.


Leave a Reply